Gelesis Investor Relations Material
Latest events
Q4 2022
Gelesis
Investor Presentation
7 Sep, 2023
Q2 2023
14 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Gelesis Holdings Inc
Access all reports
Gelesis Holdings Inc. is a biotechnology company focused on developing products for weight management and metabolic health. The company creates therapeutics designed to treat obesity and other related conditions using hydrogel technology. Gelesis’ products are intended to aid in weight loss by creating a sensation of fullness, and they are based on its proprietary biomaterials platform. The company’s offerings target individuals seeking weight management solutions and those at risk of obesity-related health issues. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NYSE.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
GLS
Country
🇺🇸 United States